000590 古汉医药
已收盘 04-14 15:00:00
资讯
新帖
简况
图解古汉医药年报:第四季度单季净利润同比增长63.21%
证券之星 · 03-31
图解古汉医药年报:第四季度单季净利润同比增长63.21%
股市必读:古汉医药(000590)3月23日收盘跌5.05%,主力净流入127.75万元
证券之星 · 03-24
股市必读:古汉医药(000590)3月23日收盘跌5.05%,主力净流入127.75万元
股市必读:3月20日古汉医药现545.96万元大宗交易
证券之星 · 03-23
股市必读:3月20日古汉医药现545.96万元大宗交易
股市必读:3月18日古汉医药现1笔折价12.46%的大宗交易 合计成交356.87万元
证券之星 · 03-19
股市必读:3月18日古汉医药现1笔折价12.46%的大宗交易 合计成交356.87万元
古汉医药(000590)披露控股股东之一致行动人增持公司股份计划,3月9日股价下跌3.32%
证券之星 · 03-09
古汉医药(000590)披露控股股东之一致行动人增持公司股份计划,3月9日股价下跌3.32%
3月9日增减持汇总:中粮科工等2家公司拟减持 古汉医药等2股增持(表)
新浪证券 · 03-09
3月9日增减持汇总:中粮科工等2家公司拟减持 古汉医药等2股增持(表)
古汉医药(000590.SZ)股东上海赛乐仙拟斥不低于2000万元实施增持
智通财经 · 03-09
古汉医药(000590.SZ)股东上海赛乐仙拟斥不低于2000万元实施增持
古汉医药:将营业收入增长、经营业绩、盈利能力、资产质量、股东回报等核心经营指标纳入考核体系
证券之星 · 03-04
古汉医药:将营业收入增长、经营业绩、盈利能力、资产质量、股东回报等核心经营指标纳入考核体系
古汉医药(000590.SZ):预计2025年净亏损4500万元—5500万元
中金财经 · 01-29
古汉医药(000590.SZ):预计2025年净亏损4500万元—5500万元
古汉医药:若满足条件将在会计年度结束后一个月内进行业绩预告
证券之星 · 01-27
古汉医药:若满足条件将在会计年度结束后一个月内进行业绩预告
股市必读:古汉医药(000590)1月15日董秘有最新回复
证券之星 · 01-16
股市必读:古汉医药(000590)1月15日董秘有最新回复
古汉医药:现有产品和服务未涉及AI医疗领域
证券之星 · 01-15
古汉医药:现有产品和服务未涉及AI医疗领域
古汉医药:1月5日高管罗怀青增持股份合计10000股
证券之星 · 01-06
古汉医药:1月5日高管罗怀青增持股份合计10000股
古汉医药(000590.SZ):全资子公司股权内部划转
中金财经 · 2025-12-30
古汉医药(000590.SZ):全资子公司股权内部划转
启迪药业最新公告:证券简称拟变更为“古汉医药”
证券之星 · 2025-12-22
启迪药业最新公告:证券简称拟变更为“古汉医药”
启迪药业(000590)披露拟变更公司名称并修订《公司章程》议案获股东会通过,12月16日股价下跌2.83%
证券之星 · 2025-12-16
启迪药业(000590)披露拟变更公司名称并修订《公司章程》议案获股东会通过,12月16日股价下跌2.83%
启迪药业:通过产品及康养文旅服务对接养老产业链需求
证券之星 · 2025-11-27
启迪药业:通过产品及康养文旅服务对接养老产业链需求
启迪药业(000590.SZ)拟更名为“古汉医药集团股份公司”
智通财经 · 2025-11-26
启迪药业(000590.SZ)拟更名为“古汉医药集团股份公司”
启迪药业:可治疗流感症状的药品有7个产品批文
证券之星 · 2025-11-20
启迪药业:可治疗流感症状的药品有7个产品批文
启迪药业(000590)发布2025年第二次临时股东大会决议公告,11月18日股价下跌1.0%
证券之星 · 2025-11-18
启迪药业(000590)发布2025年第二次临时股东大会决议公告,11月18日股价下跌1.0%
加载更多
公司概况
公司名称:
古汉医药集团股份公司
所属行业:
医药制造业
上市日期:
1996-01-19
主营业务:
古汉医药集团股份公司的主营业务是中药、化药、保健食品三大板块药品的销售。公司的主要产品是补益类、心脑血管类、儿童营养类、感冒类、清热解毒类等处方及非处方药品。公司是国家高新技术企业、湖南省主要的医药企业之一。公司拥有国家级绿色工厂及国内领先水平的智能制造生产线和检验检测设备。公司“古汉”商标为中国驰名商标,“古汉”品牌为“中华老字号”,在中药领域具有较高的知名度和美誉度,经过四十年的发展,公司在湖南省内市场取得了良好的业绩和较高的市场占有率。
发行价格:
6.00
{"stockData":{"symbol":"000590","market":"SZ","secType":"STK","nameCN":"古汉医药","latestPrice":11.34,"timestamp":1776150189000,"preClose":11.5,"halted":0,"volume":4743600,"delay":0,"changeRate":-0.0139,"floatShares":239000000,"shares":239000000,"eps":0.1021,"marketStatus":"已收盘","change":-0.16,"latestTime":"04-14 15:00:00","open":11.57,"high":11.61,"low":11.26,"amount":53860500,"amplitude":0.0304,"askPrice":11.35,"askSize":12,"bidPrice":11.34,"bidSize":588,"shortable":0,"etf":0,"ttmEps":0.1021,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1776216600000},"marketStatusCode":5,"adr":0,"adjPreClose":11.5,"symbolType":"stock","openAndCloseTimeList":[[1776130200000,1776137400000],[1776142800000,1776150000000]],"highLimit":12.65,"lowLimit":10.35,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":239471267,"isCdr":false,"pbRate":5.03,"roa":"--","peRate":111.067581,"roe":"--","epsLYR":-0.211,"committee":0.465221,"marketValue":2716000000,"turnoverRate":0.0198,"status":1,"floatMarketCap":2714000000},"requestUrl":"/m/hq/s/000590","defaultTab":"news","newsList":[{"id":"2623253883","title":"图解古汉医药年报:第四季度单季净利润同比增长63.21%","url":"https://stock-news.laohu8.com/highlight/detail?id=2623253883","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2623253883?lang=zh_cn&edition=full","pubTime":"2026-03-31 02:43","pubTimestamp":1774896236,"startTime":"0","endTime":"0","summary":"证券之星消息,古汉医药2025年年报显示,当年度公司主营收入3.38亿元,同比下降1.61%;归母净利润-5051.68万元,同比上升59.74%;扣非净利润-6213.99万元,同比上升63.41%;其中2025年第四季度,公司单季度主营收入1.13亿元,同比下降11.12%;单季度归母净利润-3569.62万元,同比上升63.21%;单季度扣非净利润-4145.8万元,同比上升69.94%;负债率38.22%,投资收益77.81万元,财务费用281.94万元,毛利率44.75%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026033100006171.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000590"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621084000","title":"股市必读:古汉医药(000590)3月23日收盘跌5.05%,主力净流入127.75万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2621084000","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2621084000?lang=zh_cn&edition=full","pubTime":"2026-03-24 04:36","pubTimestamp":1774298173,"startTime":"0","endTime":"0","summary":"截至2026年3月23日收盘,古汉医药报收于11.28元,下跌5.05%,换手率2.89%,成交量6.91万手,成交额7921.28万元。当日关注点来自交易信息汇总:古汉医药股价连续3日下跌,3月23日收报11.28元,跌5.05%。前10个交易日资金流向情况:主力资金累计净流入1659.22万元,股价累计下跌5.48% 资金流向3月23日主力资金净流入127.75万元;游资资金净流入386.46万元;散户资金净流出514.21万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026032400005119.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","000590","BK0122"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621953749","title":"股市必读:3月20日古汉医药现545.96万元大宗交易","url":"https://stock-news.laohu8.com/highlight/detail?id=2621953749","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2621953749?lang=zh_cn&edition=full","pubTime":"2026-03-23 04:11","pubTimestamp":1774210270,"startTime":"0","endTime":"0","summary":"截至2026年3月20日收盘,古汉医药报收于11.88元,下跌1.74%,换手率1.86%,成交量4.45万手,成交额5370.84万元。当日关注点来自交易信息汇总:3月20日主力资金净流出164.63万元,显示主力短期减持动向。来自交易信息汇总:同日游资资金净流入227.37万元,反映短线交易活跃。来自交易信息汇总:古汉医药当日发生545.96万元大宗交易,可能涉及机构调仓。大宗交易3月20日古汉医药现545.96万元大宗交易。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026032300001621.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000590","BK0239","BK0122"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620266285","title":"股市必读:3月18日古汉医药现1笔折价12.46%的大宗交易 合计成交356.87万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2620266285","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2620266285?lang=zh_cn&edition=full","pubTime":"2026-03-19 02:08","pubTimestamp":1773857295,"startTime":"0","endTime":"0","summary":"截至2026年3月18日收盘,古汉医药报收于12.44元,上涨2.81%,换手率1.77%,成交量4.24万手,成交额5189.87万元。当日关注点来自交易信息汇总:3月18日主力资金净流入230.59万元,呈现主动买入态势。大宗交易3月18日古汉医药现1笔折价12.46%的大宗交易,合计成交356.87万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026031900001093.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000590","BK0122","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618178627","title":"古汉医药(000590)披露控股股东之一致行动人增持公司股份计划,3月9日股价下跌3.32%","url":"https://stock-news.laohu8.com/highlight/detail?id=2618178627","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2618178627?lang=zh_cn&edition=full","pubTime":"2026-03-09 22:54","pubTimestamp":1773068054,"startTime":"0","endTime":"0","summary":"截至2026年3月9日收盘,古汉医药报收于11.93元,较前一交易日下跌3.32%,最新总市值为28.57亿元。近日,古汉医药集团股份公司发布《关于控股股东之一致行动人增持公司股份计划的公告》。公告显示,公司控股股东之一致行动人上海赛乐仙企业管理咨询有限公司基于对公司长期投资价值的认可及未来持续稳定发展的信心,计划自公告披露之日起6个月内增持公司股份,增持金额合计不低于人民币2,000万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026030900035671.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0122","000590"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618262102","title":"3月9日增减持汇总:中粮科工等2家公司拟减持 古汉医药等2股增持(表)","url":"https://stock-news.laohu8.com/highlight/detail?id=2618262102","media":"新浪证券","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2618262102?lang=zh_cn&edition=full","pubTime":"2026-03-09 21:32","pubTimestamp":1773063120,"startTime":"0","endTime":"0","summary":"炒股就看金麒麟分析师研报,权威,专业,及时,全面,助您挖掘潜力主题机会! 据统计,3月9日,盘后真兰仪表、古汉医药等两家上市公司披露增持情况。中粮科工、上大股份等两股披露拟减持情况。\n\n\n新浪声明:此消息系转载自新浪合作媒体,新浪网登载此文出于传递更多信息之目的,并不意味着赞同其观点或证实其描述。文章内容仅供参考,不构成投资建议。投资者据此操作,风险自担。\n\n\n海量资讯、精准解读,尽在新浪财经APP","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/marketresearch/2026-03-09/doc-inhqmcpk3811470.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["000590","301058","BK0221","BK0239","BK0122"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618164736","title":"古汉医药(000590.SZ)股东上海赛乐仙拟斥不低于2000万元实施增持","url":"https://stock-news.laohu8.com/highlight/detail?id=2618164736","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2618164736?lang=zh_cn&edition=full","pubTime":"2026-03-09 18:23","pubTimestamp":1773051794,"startTime":"0","endTime":"0","summary":"智通财经APP讯,古汉医药(000590.SZ)公告,公司控股股东之一致行动人上海赛乐仙企业管理咨询有限公司(简称“上海赛乐仙”)计划自本公告披露之日起6个月内增持公司股份,拟增持金额合计不低于人民币2000万元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1411702.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"古汉医药(000590.SZ)股东上海赛乐仙拟斥不低于2000万元实施增持","news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0122","000590","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616853558","title":"古汉医药:将营业收入增长、经营业绩、盈利能力、资产质量、股东回报等核心经营指标纳入考核体系","url":"https://stock-news.laohu8.com/highlight/detail?id=2616853558","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616853558?lang=zh_cn&edition=full","pubTime":"2026-03-04 20:51","pubTimestamp":1772628677,"startTime":"0","endTime":"0","summary":"证券之星消息,古汉医药03月03日在投资者关系平台上答复投资者关心的问题。公司严格遵守监管要求,不直接以股价作为考核指标,将营业收入增长、经营业绩、盈利能力、资产质量、股东回报等核心经营指标纳入管理层及经营团队考核体系,力争以业绩增长夯实市值基础,持续提升公司的内在价值与市场认可度。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026030400038081.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000590"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2607808078","title":"古汉医药(000590.SZ):预计2025年净亏损4500万元—5500万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2607808078","media":"中金财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2607808078?lang=zh_cn&edition=full","pubTime":"2026-01-29 21:27","pubTimestamp":1769693222,"startTime":"0","endTime":"0","summary":"格隆汇1月29日丨古汉医药(000590.SZ)发布2025年度业绩预告,报告期内,归属于上市公司股东的净利润为亏损4,500万元—5,500万元,上年同期亏损1.25亿元;扣除非经常性损益后的净利润为亏损5,500万元—6,500万元,上年同期亏损1.70亿元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushizhibo/20260129/31984030.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["000590","BK0239","BK0122"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2606197784","title":"古汉医药:若满足条件将在会计年度结束后一个月内进行业绩预告","url":"https://stock-news.laohu8.com/highlight/detail?id=2606197784","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606197784?lang=zh_cn&edition=full","pubTime":"2026-01-27 20:51","pubTimestamp":1769518275,"startTime":"0","endTime":"0","summary":"证券之星消息,古汉医药01月26日在投资者关系平台上答复投资者关心的问题。按照深交所规定,咱们必须要公布业绩快报,不知何时公告,古汉医药回复:尊敬的投资者,您好!根据《深圳证券交易所股票上市规则》的相关规定,若公司满足业绩预告相应条件,公司将在会计年度结束后的一个月内对年度经营情况进行业绩预告,并确定披露相关事宜。感谢您对古汉医药的关注!","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012700039507.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0122","BK0239","000590"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2603104938","title":"股市必读:古汉医药(000590)1月15日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2603104938","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603104938?lang=zh_cn&edition=full","pubTime":"2026-01-16 03:20","pubTimestamp":1768504836,"startTime":"0","endTime":"0","summary":"截至2026年1月15日收盘,古汉医药报收于11.44元,下跌0.52%,换手率1.47%,成交量3.52万手,成交额4028.93万元。董秘最新回复投资者: 尊敬的董秘您好,请问公司在AI医疗领域是否有布局?公司现有产品和服务未涉及AI医疗领域。当日关注点来自交易信息汇总:1月15日主力资金净流出280.9万元,散户资金净流入367.26万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026011600002593.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0122","BK0239","000590"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2603607260","title":"古汉医药:现有产品和服务未涉及AI医疗领域","url":"https://stock-news.laohu8.com/highlight/detail?id=2603607260","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603607260?lang=zh_cn&edition=full","pubTime":"2026-01-15 20:48","pubTimestamp":1768481304,"startTime":"0","endTime":"0","summary":"证券之星消息,古汉医药(000590)01月15日在投资者关系平台上答复投资者关心的问题。投资者提问:尊敬的董秘您好,请问公司在AI医疗领域是否有布局?后续是否有AI医疗相关的战略布局和规划?古汉医药回复:尊敬的投资者,您好!公司现有产品和服务未涉及AI医疗领域。公司致力于打造医药行业“后厂”模式,为药店终端及医药行业提供研发、工艺优化、定制化生产等全生命周期制药服务,未来将结合自身特点与市场发展积极探索新技术与现有业务的结合。感谢您对古汉医药的关注!以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026011500038642.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","000590","159891","BK0122"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2601789797","title":"古汉医药:1月5日高管罗怀青增持股份合计10000股","url":"https://stock-news.laohu8.com/highlight/detail?id=2601789797","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601789797?lang=zh_cn&edition=full","pubTime":"2026-01-06 21:01","pubTimestamp":1767704507,"startTime":"0","endTime":"0","summary":"证券之星消息,根据1月6日市场公开信息、上市公司公告及交易所披露数据整理,古汉医药(000590)最新董监高及相关人员股份变动情况:2026年1月5日公司独立董事罗怀青共增持公司股份1.0万股,占公司总股本为0.0042%。变动期间公司股价上涨5.0%,1月5日当日收盘报11.77元。古汉医药近半年内的董监高及核心技术人员增减持详情如下:古汉医药的高管列表及最新持股情况如下:该股最近90天内无机构评级。以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026010600040495.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000590","BK0122","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2595361799","title":"古汉医药(000590.SZ):全资子公司股权内部划转","url":"https://stock-news.laohu8.com/highlight/detail?id=2595361799","media":"中金财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2595361799?lang=zh_cn&edition=full","pubTime":"2025-12-30 18:37","pubTimestamp":1767091032,"startTime":"0","endTime":"0","summary":"格隆汇12月30日丨古汉医药(000590.SZ)公布,为更好地发挥公司下属子公司之间的协同效应,优化资源配置,结合公司战略规划,拟将所持有的全资子公司广东先通药业有限公司(简称“广东先通”)100%股权划转至古汉中药有限公司(简称“中药公司”)。本次股权划转完成后,广东先通成为中药公司的全资子公司,成为公司的全资孙公司。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushizhibo/20251230/31904100.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["000590","BK0122","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2593894344","title":"启迪药业最新公告:证券简称拟变更为“古汉医药”","url":"https://stock-news.laohu8.com/highlight/detail?id=2593894344","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593894344?lang=zh_cn&edition=full","pubTime":"2025-12-22 18:49","pubTimestamp":1766400581,"startTime":"0","endTime":"0","summary":"启迪药业(000590.SZ)公告称,公司第十届董事会临时会议于2025年12月22日召开,会议审议通过《关于变更公司证券简称的议案》。公司证券简称将由“启迪药业”变更为“古汉医药”,并向深圳证券交易所提交证券简称变更申请。以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025122200024941.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1574","BK1515","BK1161","BK0239","159938","161027","BK0122","000590","09939"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2591938313","title":"启迪药业(000590)披露拟变更公司名称并修订《公司章程》议案获股东会通过,12月16日股价下跌2.83%","url":"https://stock-news.laohu8.com/highlight/detail?id=2591938313","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2591938313?lang=zh_cn&edition=full","pubTime":"2025-12-16 22:25","pubTimestamp":1765895108,"startTime":"0","endTime":"0","summary":"截至2025年12月16日收盘,启迪药业报收于10.63元,较前一交易日下跌2.83%,最新总市值为25.46亿元。近日,启迪药业集团股份公司发布2025年第三次临时股东会决议公告,宣布公司于2025年12月16日召开2025年第三次临时股东会,会议以现场与网络投票相结合的方式举行。公告显示,本次股东会审议通过了关于拟变更公司名称并修订《公司章程》的议案、修订《股东会议事规则》的议案及修订《董事会议事规则》的议案。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025121600041019.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0122","000590","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2586240458","title":"启迪药业:通过产品及康养文旅服务对接养老产业链需求","url":"https://stock-news.laohu8.com/highlight/detail?id=2586240458","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586240458?lang=zh_cn&edition=full","pubTime":"2025-11-27 20:48","pubTimestamp":1764247702,"startTime":"0","endTime":"0","summary":"证券之星消息,启迪药业11月26日在投资者关系平台上答复投资者关心的问题。公司目前没有直接运营养老服务机构。公司现阶段主要通过产品、诊疗服务及康养文旅服务对接养老产业链需求。建成的古汉中药工业园区是集中医药智能制造观光、中医药文化科普研学、中医诊疗康养体验为一体的国家3A级工业旅游景区。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025112700035357.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["399812","BK0122","BK0239","000590"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2586258872","title":"启迪药业(000590.SZ)拟更名为“古汉医药集团股份公司”","url":"https://stock-news.laohu8.com/highlight/detail?id=2586258872","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586258872?lang=zh_cn&edition=full","pubTime":"2025-11-26 17:49","pubTimestamp":1764150590,"startTime":"0","endTime":"0","summary":"智通财经APP讯,启迪药业(000590.SZ)公告,公司董事会审议通过了《关于拟变更公司名称并修订<公司章程>的议案》,同意将公司名称拟变更为“古汉医药集团股份公司”,并同步修订《公司章程》的相关条款。待公司名称变更完成后,公司将根据深圳证券交易所有关规定向其申请变更证券简称。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1373942.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["000590","BK0122","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2584131510","title":"启迪药业:可治疗流感症状的药品有7个产品批文","url":"https://stock-news.laohu8.com/highlight/detail?id=2584131510","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2584131510?lang=zh_cn&edition=full","pubTime":"2025-11-20 20:48","pubTimestamp":1763642933,"startTime":"0","endTime":"0","summary":"证券之星消息,启迪药业11月20日在投资者关系平台上答复投资者关心的问题。公司可治疗流感相应症状的药品有风寒感冒颗粒、风热感冒颗粒等7个产品批文,分别具有疏风散寒、清温解毒、止咳等功效;药食同源养生食品有:甘姜饮,源自张仲景的甘草干姜汤。中医讲究辨证论治,流感每个人的症状不同,应区分寒热虚实,或在医生指导下用药。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025112000035457.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","000590","BK0122"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2584996955","title":"启迪药业(000590)发布2025年第二次临时股东大会决议公告,11月18日股价下跌1.0%","url":"https://stock-news.laohu8.com/highlight/detail?id=2584996955","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2584996955?lang=zh_cn&edition=full","pubTime":"2025-11-18 22:29","pubTimestamp":1763476162,"startTime":"0","endTime":"0","summary":"截至2025年11月18日收盘,启迪药业报收于11.9元,较前一交易日下跌1.0%,最新总市值为28.5亿元。该股当日开盘12.06元,最高12.09元,最低11.78元,成交额达4508.25万元,换手率为1.59%。近日,启迪药业集团股份公司披露了2025年第二次临时股东大会决议公告。出席会议股东共161人,代表股份占公司有表决权股份总数的45.4846%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025111800040013.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000590","BK0239","BK0122"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1776210396963,"stockEarnings":[{"period":"1week","weight":-0.0241},{"period":"1month","weight":-0.0581},{"period":"3month","weight":-0.0139},{"period":"6month","weight":0.0053},{"period":"1year","weight":0.277},{"period":"ytd","weight":0.0116}],"compareEarnings":[{"period":"1week","weight":0.0351},{"period":"1month","weight":-0.0168},{"period":"3month","weight":-0.0241},{"period":"6month","weight":0.0282},{"period":"1year","weight":0.2341},{"period":"ytd","weight":0.0146}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"古汉医药集团股份公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"15034人(较上一季度减少10.99%)","perCapita":"15921股","listingDate":"1996-01-19","address":"湖南省衡阳市蒸湘区高新区杨柳路33号","registeredCapital":"23947万元","survey":" 古汉医药集团股份公司的主营业务是中药、化药、保健食品三大板块药品的销售。公司的主要产品是补益类、心脑血管类、儿童营养类、感冒类、清热解毒类等处方及非处方药品。公司是国家高新技术企业、湖南省主要的医药企业之一。公司拥有国家级绿色工厂及国内领先水平的智能制造生产线和检验检测设备。公司“古汉”商标为中国驰名商标,“古汉”品牌为“中华老字号”,在中药领域具有较高的知名度和美誉度,经过四十年的发展,公司在湖南省内市场取得了良好的业绩和较高的市场占有率。","listedPrice":6},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.40.0","shortVersion":"4.40.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"古汉医药(000590)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供古汉医药(000590)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"古汉医药,000590,古汉医药股票,古汉医药股票老虎,古汉医药股票老虎国际,古汉医药行情,古汉医药股票行情,古汉医药股价,古汉医药股市,古汉医药股票价格,古汉医药股票交易,古汉医药股票购买,古汉医药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"古汉医药(000590)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供古汉医药(000590)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}